Search results for: 'ICT Market Forecast'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (earlie...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiatives, strengthen cybersecurity, and modernize clinic...

21 May 2021  |  North America  |  Market Research

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

Infographics

×

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...

As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...

Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...